We’re In This Together

Posted on April 6, 2020 by Angel Blair

It’s quite the understatement when I say that things across the country and around the world are very distressed right now. With the COVID-19 pandemic still impacting lives and dominating most news headlines, the virus has left most feeling anxious and concerned. We’re left with questions and fears. And to top it off, have mostly been confined indoors to socially isolate ourselves for safety. With many things unsettled and unknown, I find comfort in knowing we’re all in this together. Continue reading →

Latest Issue of The Motivator Now Available for the MS Community

Posted on April 22, 2014 by MSAA

The Motivator is MSAA’s award-winning magazine provided to the MS community and to our generous supporters. Distributed twice per year, this publication addresses the physical, emotional, and social issues that arise with MS, and provides information and support to many individuals affected by this disorder.

We’re pleased to announce that the Winter/Spring 2014 issue of The Motivator is now available to read!

Cover Story:
The Emotional and Psychological Symptoms of MS
… The symptoms of depression, anxiety, and pseudobulbar affect (PBA) are described, along with effective treatment strategies. Important information is also given on how these symptoms affect roles and relationships, sexual function, and self-image.
Read the full story

Feature Story:
…Competitive “biosimilar” drugs may soon be considered for approval. Read about how these “highly similar” drugs may affect procedure, treatment, and cost.
Read the full story

Program Notes:
…Details on MSAA’s new Swim for MS online Aquatic Center are highlighted. This national program initiative supports the awareness, understanding, and availability of swimming and aquatic exercise as a positive wellness opportunity for the MS community.
Read the full story

Read the latest issue of The Motivator

MS News Update – Highlights from CMSC 2012

Posted on July 30, 2012 by John MSAA

Highlights from The Consortium of Multiple Sclerosis Centers’ Annual Meeting

MSAA has posted a new online article giving highlights from this year’s Consortium of Multiple Sclerosis Centers’ Annual Meeting. MS experts from around the country attended this exciting conference, where the latest findings in MS research, treatments, symptom management, and patient care were presented.

Topics highlighted in this article include three new drugs presently under review by the FDA (teriflunomide, dimethyl fumarate, and alemtuzumab), while also giving the results of the Copaxone® study with lower-frequency dosing. The article explains the difficulties in understanding progressive forms of MS, presents the findings through different types of brain imaging, and provides information about a new study. Biomarkers, surrogates, and cognition are addressed in detail as well.

Read the full article on highlights from this year’s Consortium of Multiple Sclerosis Centers’ Annual Meeting.

FOLLOW MSAA ON: